Cargando…
Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients
AIMS: Islet amyloid is a hallmark in type 2 diabetic subjects, but its implication in clinical features and development of islet pathology is still unclear. METHODS: From 118 autopsy cases with type 2 diabetes, 26 cases with islet amyloid deposition (DA+) were selected. Twenty diabetic subjects with...
Autores principales: | Kamata, Kosuke, Mizukami, Hiroki, Inaba, Wataru, Tsuboi, Kentaro, Tateishi, Yoshinori, Yoshida, Taro, Yagihashi, Soroku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa UK Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196506/ https://www.ncbi.nlm.nih.gov/pubmed/25007035 http://dx.doi.org/10.3109/13506129.2014.937857 |
Ejemplares similares
-
Age‐associated changes of islet endocrine cells and the effects of body mass index in Japanese
por: Mizukami, Hiroki, et al.
Publicado: (2014) -
Dynamic pathology of islet endocrine cells in type 2 diabetes: β‐Cell growth, death, regeneration and their clinical implications
por: Yagihashi, Soroku, et al.
Publicado: (2015) -
Augmented reduction of islet β‐cell mass in Goto‐Kakizaki rats fed high‐fat diet and its suppression by pitavastatin treatment
por: Mizukami, Hiroki, et al.
Publicado: (2012) -
Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat
por: Takahashi, Kazunori, et al.
Publicado: (2012) -
Quo vadis: Where have the β-cells gone?
por: Yagihashi, Soroku, et al.
Publicado: (2015)